SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16387747
Source:
http://linkedlifedata.com/resource/pubmed/id/16387747
Search
Subject
(
51
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0019693
,
umls-concept:C0030705
,
umls-concept:C0036043
,
umls-concept:C0087111
,
umls-concept:C0181090
,
umls-concept:C0205191
,
umls-concept:C0243009
,
umls-concept:C0302614
,
umls-concept:C1512900
,
umls-concept:C1521761
,
umls-concept:C1706050
,
umls-concept:C2926735
pubmed:issue
3
pubmed:dateCreated
2006-2-7
pubmed:abstractText
To evaluate the safety of treatment interruption (TI) guided by CD4+ count in HIV-infected patients followed-up prospectively.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7513617
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0305-7453
pubmed:author
pubmed-author:ArlottiMassimoM
,
pubmed-author:BoschiAndreaA
,
pubmed-author:OrtolaniPatriziaP
,
pubmed-author:TinelliCarmineC
pubmed:issnType
Print
pubmed:volume
57
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
520-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16387747-Adolescent
,
pubmed-meshheading:16387747-Adult
,
pubmed-meshheading:16387747-Anti-HIV Agents
,
pubmed-meshheading:16387747-Antiretroviral Therapy, Highly Active
,
pubmed-meshheading:16387747-CD4 Lymphocyte Count
,
pubmed-meshheading:16387747-CD4-Positive T-Lymphocytes
,
pubmed-meshheading:16387747-Drug Administration Schedule
,
pubmed-meshheading:16387747-HIV Infections
,
pubmed-meshheading:16387747-Humans
,
pubmed-meshheading:16387747-Multivariate Analysis
,
pubmed-meshheading:16387747-Time Factors
,
pubmed-meshheading:16387747-Viral Load
pubmed:year
2006
pubmed:articleTitle
Safety and factors predicting the duration of first and second treatment interruptions guided by CD4+ cell counts in patients with chronic HIV infection.
pubmed:affiliation
Division of Infectious Diseases, AUSL Rimini, Via Settembrini 2, 47900 Rimini, Italy. boschia@libero.it
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, Non-U.S. Gov't